Youwei Yan
Nanjing Forestry University(CN)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV Research and Treatment, Biochemical and Molecular Research, Microtubule and mitosis dynamics, Chemical Synthesis and Analysis
Most-Cited Works
- → Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains(1990)563 cited
- → The structure of simian virus 40 refined at 3.1 å resolution(1996)300 cited
- → Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment(1994)292 cited
- → Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: A 2.2 Å resolution structure in a hexagonal crystal form(1998)258 cited
- → Inhibition of a Mitotic Motor Protein: Where, How, and Conformational Consequences(2003)203 cited
- → Omarigliptin (MK-3102): A Novel Long-Acting DPP-4 Inhibitor for Once-Weekly Treatment of Type 2 Diabetes(2014)167 cited
- → Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2S)-4-(2,5-Difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer(2008)156 cited
- → In VitroCharacterization of MK-1439, a Novel HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor(2013)141 cited
- → Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP(2005)136 cited
- → Discovery of 3-{5-[(6-Amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): A Potent, Orally Bioavailable HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor with Improved Potency against Key Mutant Viruses(2008)132 cited